Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Tumor DNA in Blood Samples From Patients With Late Stage Cancer and "Healthy Controls"

NCT02288754 is registered in ClinicalTrials.gov with Lexent Bio, Inc. as lead sponsor.

NCT NCT02288754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02288754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Tumor DNA in Blood Samples From Patients With Late Stage Cancer and "Healthy Controls"
Lead sponsor
Lexent Bio, Inc.
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2014
Completion date
November 30, 2020
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, tumors